A recent review of alendronate for the treatment of glucocorticoid-induced osteoporosis (GIO) found that it significantly increased bone mineral density of the lumbar spine and femoral neck in ...
Please provide your email address to receive an email when new articles are posted on . Postmenopausal women who took denosumab for a year did experienced no significant decrease in bone mineral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback